|
|
Thomson Financial Business Description:
| The Company's principal activity is that of an Investment Trust. The objective of the Company is to seek capital appreciation through investment in the worldwide biotechnology industry, principally by investing in emerging biotechnology companies. The Company is an Investment Company within the meaning of Section 833 of the Companies Act 2006. The Company has been approved by the HM Revenue and Customs as an Investment Trust for the purposes of Section 842 of the Income and Corporation Taxes Act 1988 for the year ended 31-Mar-2007. Investment management services are provided by Orbimed Capital LLC for a periodic fee of 0.65% per annum of the Company's net asset value. The agreement is terminable by either party giving notice of not less than 12 months. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on The Biotech Growth Trust PLC
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
